{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f2442bc6de29f32c4d05451/653648dfcbb2df00125f7e5e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Investigating resistant leukemia with single-cell technologies ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f2442bc6de29f32c4d05451/1698056459913-136eb101527c3513d8a9b713110eb156.jpeg?height=200","description":"<p>In this episode of Talking Techniques, Rachel Thijssen, an Assistant Professor at Amsterdam University Medical Centers (UMC; the Netherlands), discusses her research using single-cell analyses to investigate treatment-resistant leukemia cells. Rachel explains her single-cell technique called rapid capture hybridization sequencing (RaCH-seq), how she utilizes nanopore sequencing, and how she hopes that this technique can be used to gain new insights into disease and improve therapies. </p><p>&nbsp;</p><h2>Contents:</h2><p>00:00–01:35: Introduction </p><p>01:35–03:25: Single-cell sequencing in leukemia research</p><p>03:25–05:15: What is single-cell RaCH-seq?</p><p>05:15–06:10: Using nanopore sequencing for RaCH-seq</p><p>06:10–07:30: How can other researchers apply RaCH-seq to their work?</p><p>07:30–09:50: Looking to the future: spatial biology, collaborations and improved therapies&nbsp;</p>","author_name":"BioTechniques"}